Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles N Landen

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Gynecologic Oncology|August 9, 2013
Summary of the 2013 American Association for Cancer Research (AACR) Annual MeetingCharles N Landen, Ernst Lengyel
Gynecologic Oncology|August 14, 2015
Summary of the 2015 American Association for Cancer Research (AACR) Annual MeetingJeremy Chien, Charles N Landen
Gynecologic Oncology|December 11, 2013
Ovarian cancer stem cells: are they real and why are they important?Monjri M Shah, Charles N Landen
International Journal of Molecular Sciences|April 18, 2013
The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancerZachary C Dobbin, Charles N Landen
Current Protocols in Pharmacology|February 11, 2014
Isolation and characterization of potential cancer stem cells from solid human tumors--potential applicationsZachary C Dobbin, Charles N Landen
Gynecologic Oncology|May 17, 2016
Summary of the 2016 American Association for Cancer Research (AACR) Annual MeetingKatherine Fuh, Anda M Vlad, Charles N Landen
International Journal of Molecular Sciences|October 24, 2017
Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-ReviewRobert Cornelison, Danielle C Llaneza, Charles N Landen
Clinical Obstetrics and Gynecology|February 21, 2012
Molecular/genetic therapies in ovarian cancer: future opportunities and challengesAngela J Ziebarth, Charles N Landen, Ronald D Alvarez
Expert Opinion on Therapeutic Targets|November 23, 2005
EphA2 as a target for ovarian cancer therapyCharles N Landen, Michael S Kinch, Anil K Sood
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2008
Early events in the pathogenesis of epithelial ovarian cancerCharles N Landen, Michael J Birrer, Anil K Sood
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Gynecologic Oncology|August 9, 2013
Summary of the 2013 American Association for Cancer Research (AACR) Annual MeetingCharles N Landen, Ernst Lengyel
Gynecologic Oncology|August 14, 2015
Summary of the 2015 American Association for Cancer Research (AACR) Annual MeetingJeremy Chien, Charles N Landen
Gynecologic Oncology|December 11, 2013
Ovarian cancer stem cells: are they real and why are they important?Monjri M Shah, Charles N Landen
International Journal of Molecular Sciences|April 18, 2013
The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancerZachary C Dobbin, Charles N Landen
Current Protocols in Pharmacology|February 11, 2014
Isolation and characterization of potential cancer stem cells from solid human tumors--potential applicationsZachary C Dobbin, Charles N Landen
Gynecologic Oncology|May 17, 2016
Summary of the 2016 American Association for Cancer Research (AACR) Annual MeetingKatherine Fuh, Anda M Vlad, Charles N Landen
International Journal of Molecular Sciences|October 24, 2017
Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-ReviewRobert Cornelison, Danielle C Llaneza, Charles N Landen
Clinical Obstetrics and Gynecology|February 21, 2012
Molecular/genetic therapies in ovarian cancer: future opportunities and challengesAngela J Ziebarth, Charles N Landen, Ronald D Alvarez
Expert Opinion on Therapeutic Targets|November 23, 2005
EphA2 as a target for ovarian cancer therapyCharles N Landen, Michael S Kinch, Anil K Sood
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2008
Early events in the pathogenesis of epithelial ovarian cancerCharles N Landen, Michael J Birrer, Anil K Sood
Pageof 10